Source link : https://www.newshealth.biz/health-news/reassuring-data-on-glp-1-ras-and-pancreatic-cancer-risk/
PHILADELPHIA — New research provides more evidence that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) do not increase the risk for pancreatic cancer. Instead, the large electronic health record (EHR) analysis of patients with type 2 diabetes (T2D) found those taking GLP-1 RAs had a significantly lower risk for pancreatic cancer than peers on other […]
Author : News Health
Publish date : 2024-11-15 10:36:06
Copyright for syndicated content belongs to the linked Source.
inHealth